Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)

52
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
03/26/2015 03/27/2015 03/30/2015 03/31/2015 04/01/2015 Date
102.4(c) 103.4(c) 106.25(c) 104.55(c) 105.8 Last
835 633 450 501 404 680 582 783 538 793 Volume
-1.16% +0.98% +2.76% -1.60% +1.20% Change
More quotes
Financials (€)
Sales 2015 12 788 M
EBIT 2015 3 058 M
Net income 2015 1 393 M
Debt 2015 1 336 M
Yield 2015 1,03%
Sales 2016 13 856 M
EBIT 2016 3 335 M
Net income 2016 1 606 M
Debt 2016 1 076 M
Yield 2016 1,14%
PER 2015 31,63
PER 2016 27,25
EV / Sales 2015 1,16x
EV / Sales 2016 1,05x
Capitalization 13 512 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.The company operates through four divisions: Merck Serono, Consumer Health, Performance Materials & Merck Millipore.The Merck Serono division is biopharmaceutical division which markets both chemical and... 
Sector
Pharmaceuticals
Calendar
04/17Shareholder meeting
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
12:09p MERCK KGAA : Serono and MMV Sign Agreement to Develop Potential Antimalarial The..
09:23a MERCK KGAA : Serono and Medicines for Malaria Venture Sign Agreement to Develop ..
03/31 MERCK KGAA : Innovations and Concepts with Added Value: Merck at the in-cosmetic..
03/30 MERCK KGAA : Presents Future Innovations with the 3D Tour “Create the Futu..
03/30 ZIOPHARM-Intrexon Synthetic Immuno-Oncology Programs Strengthened Through Col..
03/24 MERCK KGAA : Release according to Article 26, Section 1 of the WpHG with the obj..
03/23 MERCK KGAA : Supports Schistosomiasis Education in Mozambique
03/22 MERCK KGAA : supports schistosomiasis education in Mozambique
More news
Sector news : Specialty & Advanced Pharmaceuticals
01:27p OPKO HEALTH : Conversion Right Triggered on OPKO 3.0% Convertible Senior Notes
01:18pDJShire Files 8K - Other Events
01:01p ELI LILLY : Lilly Confirms Date and Conference Call for First-Quarter 2015 Finan..
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2014Prices move higher as positive news are released
2014A gap-filling is anticipated
More Strategies
News from SeekingAlpha
03/19 MERCK : Why Is Sigma-Aldrich's Deal With Roche Positive For Investors?
03/02 Investors Are Best To Avoid The iShares Nasdaq Biotechnology ETF (IBB)
03/01 Some Companies Are More Wonderful Than Others
02/27 SEEKING ALPHA'S BIOTECH WEEKLY : Achillion Overdone, Sanofi's Toujeo A Go, And M..
02/27 WHO decision on Ebola mass vaccination not until August or later


Comments 
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF